Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
BackgroundAlzheimer’s disease (AD) is a progressive neurodegenerative disorder, with mild cognitive impairment (MCI) often serving as its precursor stage. Early intervention at the MCI stage can significantly delay AD onset.MethodsThis study employed untargeted urine metabolomics, with data obtained...
Saved in:
Main Authors: | Xiaoya Feng, Shenglan Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2025.1530046/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-based biomarkers in mild behavioral impairment: an updated overview
by: Efthalia Angelopoulou, et al.
Published: (2025-02-01) -
Untargeted Metabolomics Reveals the Metabolic Characteristics and Biomarkers of Antioxidant Properties of Gardeniae Fructus from Different Geographical Origins in China
by: Wu Jiang, et al.
Published: (2025-01-01) -
Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01) -
Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform
by: Marcella Catania, et al.
Published: (2025-01-01) -
Untargeted Metabolomics Reveals Key Differences Between Yak, Buffalo, and Cow Colostrum Based on UHPLC-ESI-MS/MS
by: Yuzhuo Wang, et al.
Published: (2025-01-01)